Cancer Research Cell Death Mechanisms and Cancer Therapy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hakuma, N.
Right arrow Articles by Dosaka-Akita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hakuma, N.
Right arrow Articles by Dosaka-Akita, H.
[Cancer Research 65, 10776-10782, December 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

E1AF/PEA3 Activates the Rho/Rho-Associated Kinase Pathway to Increase the Malignancy Potential of Non–Small-Cell Lung Cancer Cells

Nobuyuki Hakuma1, Ichiro Kinoshita2, Yasushi Shimizu2, Koichi Yamazaki1, Koichi Yoshida3, Masaharu Nishimura1 and Hirotoshi Dosaka-Akita2

1 First Department of Medicine and 2 Department of Medical Oncology, Hokkaido University Graduate School of Medicine and 3 Department of Biology, Sapporo Medical University School of Medicine, Sapporo, Japan

Requests for reprints: Ichiro Kinoshita, Department of Medical Oncology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan. Phone: 81-11-706-5551; Fax: 81-11-706-5077; E-mail: kinoshii{at}med.hokudai.ac.jp.

E1AF/PEA3, an Ets family transcription factor, is frequently overexpressed in non–small-cell lung cancers (NSCLCs). Overexpression of E1AF increases motility and invasion of VMRC-LCD and NCI-H226 NSCLC cells, which lack endogenous E1AF expression, and the effect is synergistically increased by hepatocyte growth factor (HGF). The small GTPase Rho/Rho-associated kinase (ROCK) pathway is also involved in motility and invasion. To determine the role of the Rho/ROCK pathway in malignant phenotypes induced by E1AF, we analyzed VMRC-LCD cells transfected with an E1AF expression vector (LCD-E1AF cells) or with empty vector (LCD-vector cells). LCD-E1AF cells had more GTP-bound (active) Rho than LCD-vector cells and Rho activation was synergistically increased by HGF. The Rho activation by E1AF and HGF was also shown in NCI-H226 cells. Phosphorylation of myosin light chain (MLC), a downstream effector of ROCK signaling, was higher in LCD-E1AF cells than in LCD-vector cells, especially under HGF treatment. A specific ROCK inhibitor, Y27632, strongly suppressed MLC phosphorylation, cell motility, and invasion. In nude mice implanted s.c. and intrapulmonarily, LCD-E1AF cells made more local tumors than LCD-vector cells (six of six versus one of seven mice and four of seven versus one of seven mice, respectively). Three of the four mice with lung tumors from LCD-E1AF cells had lymph node metastases whereas the mouse with LCD-vector tumors did not. LCD-E1AF tumors showed higher MLC phosphorylation than LCD-vector tumors. These results suggest that E1AF activates the Rho/ROCK pathway in an HGF-enhanced manner and its activation is important in E1AF-induced motility and invasion as well as tumorigenesis and metastasis in NSCLC cells.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. A. Sloan, H. A. Marquez, J. Li, Y. Cao, A. Hinds, C. J. O'Hara, S. Kathuria, M. I. Ramirez, M. C. Williams, and H. Kathuria
Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines
Carcinogenesis, August 1, 2009; 30(8): 1433 - 1442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Ren, H. Jin, C. Bian, H. He, X. Liu, S. Zhang, Y. Wang, and R.-g. Shao
MR-1 Modulates Proliferation and Migration of Human Hepatoma HepG2 Cells through Myosin Light Chains-2 (MLC2)/Focal Adhesion Kinase (FAK)/Akt Signaling Pathway
J. Biol. Chem., December 19, 2008; 283(51): 35598 - 35605.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Firlej, F. Ladam, G. Brysbaert, P. Dumont, F. Fuks, Y. de Launoit, A. Benecke, and A. Chotteau-Lelievre
Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription
J. Cell Sci., October 15, 2008; 121(20): 3393 - 3402.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Wei, D. Liu, Y. Ge, F. Zhou, J. Xu, H. Chen, J. Gu, and J. Jiang
Identification of E1AF as a Target Gene of E2F1-induced Apoptosis in Response to DNA Damage
J. Biochem., October 1, 2008; 144(4): 539 - 546.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Jiang, Y. Wei, J. Shen, D. Liu, X. Chen, J. Zhou, H. Zong, X. Yun, X. Kong, S. Zhang, et al.
Functional Interaction of E1AF and Sp1 in Glioma Invasion
Mol. Cell. Biol., December 15, 2007; 27(24): 8770 - 8782.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.